H19 and ovarian carcinoma: We also evaluated the prognostic ability of high H19 expression in three additional female cancer subtypes including uterine carcinosarcoma (n=57), breast cancer (n=1215), and ovarian cancer (n=266 and n=419) from the TCGA datasets.